The Joint Committee on Vaccination and Immunisation has advised against the provision of COVID-19 vaccines to 12–15-year-olds without underlying health conditions
In their latest statement, the Joint Committee on Vaccination and Immunisation (JCVI) has not advised that COVID-19 vaccination be offered to those aged 12–15 years who do not have underlying health conditions that put them at risk of severe COVID-19.
Given the low risk of serious disease in those aged 12–15 years without an underlying health condition that puts them at increased risk, the JCVI says it has taken a precautionary approach, describing the considerations on the potential harms and benefits of vaccination as ‘very finely balanced’.
The JCVI previously offered advice regarding the vaccination of children aged 12–15 years with underlying health conditions. Following consideration of the updated data from clinical trials, the advisory group recommends that the offer of a course of COVID-19 vaccination should be expanded to include children in this age group with the following health conditions:
- haematological malignancy
- sickle cell disease
- type 1 diabetes
- congenital heart disease
- other health conditions as described in COVID-19: the green book, chapter 14a.